Grifols (GRFS) Other financing activities (2011 - 2020)

Grifols (GRFS) reported Other financing activities of $5.3 million for Q1 2020, down 54.36% on a YoY basis from $11.6 million in Q2 2019, and down 52.75% quarter-over-quarter from $11.2 million in Q4 2019.

Grifols (GRFS) Other financing activities (2011 - 2020) Analysis & Trends

Grifols has reported Other financing activities for 9 years, with the latest figure at $5.3 million in Q1 2020.

  • For the quarter ending Q1 2020, Other financing activities fell 54.36% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2020 stood at $27.4 million (up 185.1% YoY), and the FY2025 full-year result was $43.1 million, down 22.49% from the prior year.
  • Other financing activities for Q1 2020 stood at $5.3 million, down from $11.2 million in the prior quarter.
  • The five-year high for Other financing activities was $273.3 million in Q2 2017, with the low at -$103.6 million in Q1 2017.
  • Historically, Other financing activities has averaged $29.9 million across 5 years, with a median of $5.3 million in 2020.
  • Annual changes were most pronounced in 2016 — Other financing activities slumped 1745.48% — and 2017, when it soared 2902.98%.
  • Grifols' Other financing activities stood at $6.1 million in 2016, then surged by 2902.98% to $182.0 million in 2017, then sank by 100.39% to -$700817.4 in 2018, then surged by 1701.54% to $11.2 million in 2019, then plunged by 52.75% to $5.3 million in 2020.
  • The last three Other financing activities figures came in at $5.3 million (Q1 2020), $11.2 million (Q4 2019), and $11.6 million (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols 6.05 Bn 5.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2020 5.30 Mn
Mar 31, 2020 5.30 Mn
Dec 31, 2019 11.22 Mn
Dec 31, 2019 11.22 Mn
Mar 31, 2019 11.62 Mn
Mar 31, 2019 11.62 Mn
Dec 31, 2018 -700,817.41
Dec 31, 2018 -700,817.41
Jun 30, 2018 -2.48 Mn
Jun 30, 2018 -2.48 Mn
Mar 31, 2018 1.18 Mn
Mar 31, 2018 1.18 Mn
Dec 31, 2017 181.96 Mn
Dec 31, 2017 181.96 Mn
Jun 30, 2017 273.32 Mn
Jun 30, 2017 273.32 Mn
Mar 31, 2017 -103.56 Mn
Mar 31, 2017 -103.56 Mn
Dec 31, 2016 6.06 Mn
Dec 31, 2016 6.06 Mn